Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVRH.L Regulatory News (EVRH)

  • There is currently no data for EVRH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

4 Apr 2016 11:56

RNS Number : 0740U
Armstrong Ventures PLC
04 April 2016
 

 

 

Armstrong Ventures plc

 

("Armstrong" or the "Company")

 

 

Final Results for the year ended 31 December 2015

 

 

Armstrong (AIM:AVO), the AIM listed company investing in the media, technology and healthcare sectors, today announces its audited final results for the year ended 31 December 2015.

 

The audited Report and Accounts for the year ended 31 December 2015 will shortly be sent to shareholders and will also be available on the Company's website: www.armstrongventures.com.

 

 

For further information please contact:

 

 

Armstrong Ventures plc

 

Sean Nicolson

avp@nicolsons.eu

 

 

Cairn Financial Advisers LLP (Nomad)

 

Sandy Jamieson/James Caithie

Tel: +44 20 7148 7900

 

 

Peterhouse Corporate Finance Limited

 

Eran Zucker/Lucy Williams

Tel: +44 20 7469 0930

 

 

 

Chairman's Statement

 

Introduction

 

I am pleased to welcome you to my first report as Chairman of Armstrong for the year ended 31 December 2015.

 

Financial Review

 

The year under review has two distinct periods. The first period ended on 17 July 2015. Prior to that date the Company had very limited cash resources and had spent some time seeking investment opportunities in the resources and energy sectors. At the general meeting held on 17 July 2015 shareholders approved resolutions in respect of the issue of 19,402,916,660 ordinary shares to raise £2.33 million before expenses and the Company's investing policy was changed to focus on opportunities in the media, technology and healthcare sectors. On 17 July 2015 Peter Read and I joined the board and Manish Kotecha and Peter Redmond resigned on that date. On 20 August 2015 Haresh Kanabar resigned as a director.

 

During the year under review the Company operated as an investing company reviewing investment opportunities in line with the Company's policies in force during the year. As such, the Company did not have any operating businesses. The Company recorded a loss of £322,186 and a loss per share of 0.003p. This compares to a corresponding loss last year of £184,079 (a loss per share of 0.008p).

 

Investment Strategy

 

The board believes that the Company's new investing focus allied with an appropriate level of cash resources will offer a realistic opportunity to identify and invest in businesses with the potential to appreciate in value in the short to medium term and to enhance shareholder value. Since Peter Read and I were appointed to the board, we have taken active steps to seek out such investment propositions.

 

The board is seeking to invest in businesses in the media, technology and healthcare sectors which have some or all of the following characteristics:

 

• strong management with a proven track record;

 

• ready for investment without the need for material re-structuring by the Company;

 

• generating positive cash flows or likely to do so in the short term;

 

• by the injection of new finances or specialist management, the Company can enhance the prospects and therefore the future value of the investment;

 

• the potential to deliver significant returns for the Company.

 

Whilst the board will be principally focused on making an investment in private businesses, investments in listed businesses will also be considered if this presents, in the board's judgement, a clear opportunity for investment growth. With the board's experience, the Company intends to be an active investor in situations where the Company can make a clear contribution to the progress and development of the investment.

 

The directors believe that their broad collective experience together with their extensive network of contacts will assist them in the identification, evaluation and funding of appropriate investment opportunities. When necessary, other external professionals will be engaged to assist in the due diligence on prospective targets and their management teams. The board will also consider appointing additional directors with relevant experience if required.

 

There will be no limit on the number of projects in which the Company may invest. The Company's financial resources may be invested in a number of propositions or in just one investment, which may be treated as a reverse takeover under Rule 14 of the AIM Rules for Companies. Where the Company builds a portfolio of related assets it is possible that there may be cross-holdings between such assets. The Company may invest through debt and similar instruments.

 

The board's primary objective is to secure for the shareholders the best possible value consistent with achieving, over time, both capital growth and income for shareholders.

 

MelodyVR

 

On 13 January 2016 (which falls outside the period under review), the Company invested £212,500 in MelodyVR Ltd (MelodyVR) by means of secured convertible loan notes (Loan Notes). On 30 March 2016 the Company invested a further £57,500 in MelodyVR by means of additional Loan Notes.

 

MelodyVR was established in early 2015 to create virtual reality content by capturing live music performances. Virtual reality (VR) is a term used to describe a three dimensional environment which can be explored and interacted with by a user. VR content created by MelodyVR will be viewed using VR headsets that are currently being developed by a number of technology companies including Oculus (owned by Facebook), HTC, Google, Sony and Samsung, providing users with an immersive 360 degree experience.

 

MelodyVR has developed its own technology for the recording and live streaming of music performances. MelodyVR plans to make live and recorded music content available to users via its own app and third party VR platforms. It is intended that the MelodyVR app will be deployed across Oculus Rift, Android, iOS, Samsung Gear VR, HTC Vive, Playstation VR and other platforms.

 

MelodyVR has entered into a number of exclusivity agreements with some of the major music festival and event promoters facilitating the filming and live broadcast of music events in a virtual reality format. It is intended that the MelodyVR app will be launched in 2016.

 

The Loan Notes bear interest at a rate of 10% per annum and are repayable on or before 31 March 2017. The Loan Notes may be converted at the option of Armstrong into equity shares in MelodyVR on 31 March 2017 or earlier upon the sale or listing of MelodyVR or upon the raising of equity finance by MelodyVR.

 

The Company's investment in MelodyVR is relatively small in proportion to the Company's cash resources. If the Loan Notes are converted the Company would have a minority interest in MelodyVR. However, the anticipated launches in 2016 of VR headsets by a number of major manufacturers, means that MelodyVR premium music service could develop very rapidly. In such circumstances, the Company would consider converting its Loan Notes into an equity holding in MelodyVR. In addition, as MelodyVR grows, the Company would also consider making further debt and equity investments.

 

Outlook

 

The Company is now well positioned to move forward and will continue pursuing an investment strategy that seeks to generate value for shareholders through considered investments in high performance, ambitious businesses offering high growth opportunities in the media, technology and healthcare sectors. The board of Armstrong is excited by the opportunities offered by companies such as MelodyVR that provide content to be used on the VR headsets being launched by a number of major technology companies in 2016. The board continues to explore VR and other investment opportunities.

 

Sean Nicolson

Chairman

1 April 2016

 

 

 

STATEMENT OF COMPREHENSIVE INCOME

 

FOR THE YEAR ENDED 31 DECEMBER 2015

 

 

 

 

2015

2014

 

Note

£

£

 

 

 

 

Continuing operations:

 

-

-

Administrative expenses

 

(326,788)

(184,079)

 

 

------------------

-------------------

OPERATING LOSS

 

(326,788)

(184,079)

 

 

 

 

Finance income

 

4,602

-

 

 

------------------

-------------------

LOSS FOR THE YEAR BEFORE TAXATION

 

(322,186)

(184,079)

 

 

 

 

Taxation

 

-

-

 

 

------------------

-------------------

NET LOSS AND TOTAL COMPREHENSIVE INCOME

 

 

 

FOR THE YEAR

 

(322,186)

(184,079)

 

 

------------------

-------------------

LOSS PER SHARE - basic and diluted from continuing operations

2

(0.003)p

(0.008)p

 

 

========

=========

 

 

 

 

 

 

 

 

 

 

STATEMENT OF CHANGES IN EQUITY

 

FOR THE YEAR ENDED 31 DECEMBER 2015

 

 

 

Share

Share

Share option

Retained

Total

 

capital

Premium

Reserve

Losses

Equity

 

£

£

£

£

£

 

 

 

 

 

 

Balance at 1 January 2014

818,360

4,262,258

-

(4,694,814)

385,804

Loss for the year and total

 

 

 

 

 

comprehensive loss for the year

-

-

-

(184,079)

(184,079)

 

 

 

 

 

 

Share issue

157,143

172,857

-

-

330,000

Share issue costs

-

(9,915)

 

 

(9,915)

Grant of share options

-

-

30,550

-

30,550

 

------------------

--------------------

------------------

---------------------

-----------------

Balance at 31 December 2014

975,503

4,425,200

30,550

(4,878,893)

552,360

Loss for the year and total

 

 

 

 

 

comprehensive loss for the year

-

-

-

(322,186)

(322,186)

 

------------------

--------------------

------------------

---------------------

-----------------

 

975,503

4,425,200

30,550

(5,210,079)

221,174

Share issue

1,950,250

392,042

-

-

2,342,292

Share issue costs

-

(293,850)

-

-

(293,850)

Options lapsed

-

-

(30,550)

30,550

-

Grant of share options/warrants

-

-

110,762

-

110,762

 

------------------

--------------------

------------------

------------------

-----------------

Balance at 31 December 2015

2,925,753

4,523,392

110,762

(5,170,529)

2,389,378

 

========

==========

========

========

========

 

 

 

 

 

 

 

 

 

STATEMENT OF FINANCIAL POSITION

 

FOR THE YEAR ENDED 31 DECEMBER 2015

 

 

 

 

2015

2014

 

Note

£

£

 

 

 

 

NON-CURRENT ASSETS

 

 

 

 

 

 

 

Available for sale investments

 

-

-

 

 

------------------

-------------------

 

 

-

-

 

 

------------------

-------------------

 

 

CURRENT ASSETS

 

 

 

 

 

 

 

Trade and other receivables

 

5,024

19,315

Cash and cash equivalents

 

2,401,021

564,759

 

 

------------------

-------------------

TOTAL ASSETS

 

2,406,045

584,074

 

 

========

=========

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

Trade and other payables

 

16,667

31,714

 

 

------------------

-------------------

NET ASSETS

 

2,389,378

552,360

 

 

========

=========

 

 

 

 

EQUITY

 

 

 

 

 

 

 

Share capital

 

2,925,753

975,503

Share premium account

3

4,523,392

4,425,200

Share option reserve

 

110,762

30,550

Retained earnings

 

(5,170,529)

(4,878,893)

 

 

------------------

--------------------

TOTAL EQUITY

 

2,389,378

552,360

 

 

=========

==========

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STATEMENT OF CASH FLOWS

 

FOR THE YEAR ENDED 31 DECEMBER 2015

 

 

 

 

2015

2014

 

Note

£

£

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

Loss before taxation

 

(322,186)

(184,079)

Adjustments for:

 

 

 

Share based payment charge

 

110,762

30,550

 

 

------------------

------------------

OPERATING CASHFLOW BEFORE WORKING CAPITAL CHANGES

 

 

(211,424)

 

(153,529)

 

 

 

 

Decrease/(Increase) in trade and other receivables

 

14,290

(16,946)

(Decrease)/Increase in trade and other payables

 

(15,046)

1,800

 

 

------------------

------------------

NET CASH OUTFLOW FROM OPERATING ACTIVITIES

 

(212,180)

(168,675)

 

 

------------------

------------------

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

Issue of shares

 

2,342,292

330,000

Share issue costs

 

(293,850)

(9,915)

 

 

------------------

------------------

NET CASH INFLOW FROM FINANCING ACTIVITIES

 

2,048,442

320,085

 

 

=========

=========

 

 

 

 

NET INCREASE IN CASH AND CASH EQUIVALENTS

 

1,836,262

151,401

 

 

 

 

Cash and cash equivalents brought forward

 

564,759

413,349

 

 

------------------

------------------

CASH AND CASH EQUIVALENTS CARRIED FORWARD

 

2,401,021

564,759

 

 

=========

=========

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOTES TO THE FINANCIAL STATEMENTS

 

1. GENERAL INFORMATION

 

Armstrong Ventures plc is a public limited company incorporated in England and Wales. The shares of the Company are quoted on the AIM stock exchange.

 

 

2. EARNINGS PER SHARE

 

The basic earnings per share is based on the loss for the year divided by the weighted average number of shares in issue during the year. The weighted average number of ordinary shares for the year ended 31 December 2015 assumes that all shares have been included in the computation based on the weighted average number of days since issue.

 

2015

2014

 

£

£

 

Loss attributable to equity holders of the Company:

 

 

 

Continuing and total operations

(322,186)

(184,079)

 

-------------------

------------------

 

 

No. of shares

No. of shares

 

 

Weighted average number of ordinary shares in issue for basic and fully

 

diluted earnings

12,611,922,485

2,398,170,370

 

-----------------------

---------------------------

 

 

Pence per

Pence per

 

Share

share

 

Loss per share

 

 

Basic and diluted:

 

Continuing and total operations

(0.003)p

(0.008)p

 

=========

==========

 

 

 

3.

ISSUED SHARE CAPITAL

Number of

Nominal

Share

 

Shares

Value

premium

 

Issued and fully paid

No.

£

£

 

At 31 December 2014:

 

Ordinary shares of 0.01p each

3,672,534,360

367,254

 

Deferred shares of 0.24p each

150,520,616

361,249

 

Deferred shares of 0.95p each

26,000,000

247,000

 

-------------------------

-------------------

--------------------

 

3,849,054,976

975,503

4,425,200

 

=============

=========

=========

 

Issue of new shares

 

Ordinary shares of 0.01p each

19,502,499,995

1,950,250

392,042

 

 

Cost of issue

(293,850)

 

 

-------------------------

-------------------

--------------------

 

23,351,554,971

1,950,250

98,192

 

=============

=========

=========

 

 

At 31 December 2015:

 

Ordinary shares of 0.01p each

23,175,034,355

2,317,504

 

Deferred shares of 0.24p each

150,520,616

361,249

 

Deferred shares of 0.95p each

26,000,000

247,000

 

-------------------------

-------------------

--------------------

 

23,351,554,971

2,925,753

4,523,392

 

=============

=========

=========

 

The deferred shares do not confer upon the holders right to any dividends or the right to attend or vote at general meetings of the Company.

 

On 17 July 2015 the Company issued 19,402,916,660 ordinary shares of 0.01p each for cash at 0.012p per share, raising £2,328,250 before expenses.

 

On 4 December 2015 the company issued 99,583,335 ordinary shares of 0.01p each for cash at 0.014p per share under the terms of the exercise of warrants raising £13,941.

 

 

4. SHARE OPTIONS AND DIRECTOR WARRANTS

 

EQUITY-SETTLED SHARE OPTION SCHEME

 

The company operates share-based payment arrangements to remunerate directors and key employees in the form of warrants and has previously operated a share option scheme. Equity-settled share-based payments are measured at fair value (excluding the effect of non-market based vesting conditions) at the date of grant. The fair value determined at the grant date of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Company's estimate of shares that will eventually vest and adjusted for the effect of non-market based vesting conditions.

 

On 18 February 2014, Haresh Kanabar and Manish Kotecha were granted options to subscribe for 147,077,405 and 63,033, 173 new ordinary shares, respectively, at an exercise price of 0.025p per share. The vesting conditions of such options were that the mid market closing price of the Company's ordinary shares is at or above 0.04p at close of business on five consecutive trading days. Mr Kanabar and Mr Kotecha resigned on 20 August 2015 and 17 July 2015 respectively. On the dates of their respective resignations the option vesting conditions had not been satisfied and so the options expired in accordance with their terms on the respective resignation dates.

 

The following table sets out the details of these options granted:

 

 

 

Number of

 

 

Number of

 

 

 

 

options at

 

 

options at

 

 

 

 

31 December

Lapsed in

Exercised

31 December

Exercise

Expiry

 

Option holder

2014

the year

in the year

2015

price

date

 

 

 

 

 

 

 

 

 

Haresh Kanabar

147,077,405

(147,077,405)

-

-

0.025p

20.8.2015

 

Manish Kotecha

63,033,173

(63,033,173)

-

-

0.025p

17.7.2015

-------------------------

-------------------------

--------------------

--------------------

------------------

-----------------

 

 

210,110,578

(210,110,578)

-

-

 

 

===========

============

==========

==========

 

 

 

 

 

 

 

 

On 31 July 2015 the Company issued 461,509,020 warrants to both Sean Nicolson and Peter Read as part of their remuneration terms ("Warrants"). The Warrants are exercisable at 0.012p per ordinary share and have an expiry date of 31 July 2020.

 

The fair value of these options was determined using the Black-Scholes option pricing model and was 0.01199p per option.

 

The significant inputs to the model in respect of the options granted were as follows:

 

 

2015

2014

 

 

Grant date shared price

0.012p

0.025p

 

Exercise share price

0.012p

0.025p

 

No. of share options

923,018,040

210,110,578

 

Risk free rate

0.5%

0.5%

 

Expected volatility

50%

50%

 

Expected option life

5 years

10 years

 

Calculated fair value per share

0.01199p

0.01454p

 

The total share-based payment expense recognised in the income statement for the year ended 31 December 2015 in respect of share options granted was £110,762.

 

 

Number of

Issued in

Issued in the

Exercised

Number of

 

 

 

Warrants at

the year

year (share

in the

Warrants at

 

 

 

31 December

(services)

subscription)

year

31 December

Exercise

Expiry

Option holder

2014

 

 

 

2015

price

date

 

 

 

 

 

 

 

 

Sean Nicolson

-

461,509,020

41,666,666

-

503,175,686

0.012p

31.7.2020

Peter Read

-

461,509,020

41,666,666

-

503,175,686

0.012p

31.7.2020

-------------------------

------------------------

-------------------------

--------------------

---------------------------

------------------

-----------------

 

-

923,018,040

83,333,332

-

1,006,351,372

 

 

============

===========

============

==========

=============

 

 

 

 

 

 

 

 

 

As a result of the placing on 17 July 2015, the company has created and issued a total of 4,222,916,655 warrants. One warrant has been issued for every four new shares subscribed for by the placees pursuant to the placing. These warrants may be exercised at any time on or before 31 July 2018 and shall entitle the warrant holder to subscribe for one Ordinary share for each warrant help at 0.014p.

 

 

5. RELATED PARTY TRANSACTIONS

 

During the reporting period the Company was invoiced £35,600 for management services by Poonam & Roshni Limited, a company controlled by Haresh Kanabar, £29,000 for management services by Remkay Limited, a company controlled by Manish Kotecha, and £34,000 for management services by Catalyst Corporate Consultants Limited, a company controlled by Peter Redmond. These amounts have been included in directors' remuneration.

 

On 31 July 2015 the Company issued 461,509,020 warrants to both Sean Nicolson and Peter Read as part of their remuneration terms ("Warrants"). The Warrants are exercisable at 0.012p per ordinary share and have an expiry date of 31 July 2020. Also issued were 41,666,666 share subscription warrants to both Sean Nicolson and Peter Read.

 

 

6 POST YEAR END EVENTS

 

On 13 January 2016 the Company invested £212,500 in MelodyVR Ltd (MelodyVR) by means of secured convertible loan notes (Loan Notes). The Loan Notes bear interest at a rate of 10% per annum and are repayable on or before 31 March 2017. The Loan Notes may be converted at the option of Armstrong into equity shares in MelodyVR on 31 March 2017 or earlier upon the sale or listing of MelodyVR or upon the raising of equity finance by MelodyVR. A further loan note investment of £57,500 was made on 30 March 2016 on the same terms as the prior investment.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR USVRRNUASRAR
Date   Source Headline
21st May 202012:00 pmRNSLive Nation partnership for ‘Wireless Connect’
15th May 20207:00 amRNSMelodyVR launch content studio and 'Live from LA'
11th May 20201:54 pmRNSResult of AGM
4th May 20207:00 amRNSLaunch of 'On stage', a free-to-fan content series
20th Apr 20204:40 pmRNSSecond Price Monitoring Extn
20th Apr 20204:35 pmRNSPrice Monitoring Extension
20th Apr 20202:06 pmRNSSecond Price Monitoring Extn
20th Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 202011:06 amRNSSecond Price Monitoring Extn
20th Apr 202011:00 amRNSPrice Monitoring Extension
16th Apr 20205:52 pmRNSHolding(s) in Company
16th Apr 202012:37 pmRNSNotice of AGM and proposed change of name
2nd Apr 20204:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:37 pmRNSPrice Monitoring Extension
2nd Apr 20202:06 pmRNSSecond Price Monitoring Extn
2nd Apr 20202:00 pmRNSPrice Monitoring Extension
2nd Apr 20209:05 amRNSSecond Price Monitoring Extn
2nd Apr 20209:00 amRNSPrice Monitoring Extension
1st Apr 20206:27 pmRNSHolding(s) in Company
31st Mar 202012:08 pmRNSHolding(s) in Company
23rd Mar 20203:30 pmRNSSuccessful fundraise of $12 million
23rd Mar 20207:00 amRNSAccelerated bookbuild
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:40 pmRNSPrice Monitoring Extension
20th Mar 20202:06 pmRNSSecond Price Monitoring Extn
20th Mar 20202:01 pmRNSPrice Monitoring Extension
20th Mar 202011:06 amRNSSecond Price Monitoring Extn
20th Mar 202011:00 amRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20202:06 pmRNSSecond Price Monitoring Extn
19th Mar 20202:00 pmRNSPrice Monitoring Extension
19th Mar 202011:05 amRNSSecond Price Monitoring Extn
19th Mar 202011:00 amRNSPrice Monitoring Extension
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 20202:06 pmRNSSecond Price Monitoring Extn
18th Mar 20202:01 pmRNSPrice Monitoring Extension
18th Mar 202011:05 amRNSSecond Price Monitoring Extn
18th Mar 202011:00 amRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSCOVID-19 Strategy Update
9th Mar 20202:06 pmRNSSecond Price Monitoring Extn
9th Mar 20202:01 pmRNSPrice Monitoring Extension
9th Mar 202011:06 amRNSSecond Price Monitoring Extn
9th Mar 202011:01 amRNSPrice Monitoring Extension
14th Jan 20205:25 pmRNSHolding(s) in Company
6th Jan 20207:00 amRNSOption Exercise valuing the Company at £220m
5th Dec 20199:49 amRNSMelodyVR extends O2 Partnership
4th Dec 20191:06 pmRNSMelodyVR featured by Google in Best Apps of 2019
21st Nov 201912:00 pmRNSMelodyVR featured by Apple Inc. as App of the Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.